Search Login Register

Toremifene (Fareston) Summary

Description: A first generation selective estrogen receptor modulator (SERM). Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.

Also Known As: Fareston; FC-1157a; Toremifene Citrate; Toremifene Citrate (1:1); Toremifene, (E)-Isomer Show All >>

Networked: 369 relevant articles (65 outcomes, 97 trials/studies) for this Drug

Key Diseases for which Toremifene is Relevant

  1. Breast Neoplasms (Breast Cancer) : 41 outcomes 58 studies in 228 results
  2. Prostatic Neoplasms (Prostate Cancer) : 9 outcomes 15 studies in 29 results
  3. Neoplasms (Cancer) : 7 outcomes 15 studies in 80 results
  4. Prostatic Intraepithelial Neoplasia : 2 outcomes 2 studies in 6 results
  5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) : 2 outcomes 2 studies in 5 results
Show All >>

Drugs Related to Toremifene

  1. Tamoxifen
  2. Toremifene (Fareston)
  3. Estrogens (Estrogen)
  4. Selective Estrogen Receptor Modulators (SERM)
  5. Estrogen Receptor Modulators (Antiestrogen)
  6. Hormones
  7. triphenylethylene
  8. Aromatase (CYP19)
  9. Paclitaxel (Taxol)
  10. Gonadotropin-Releasing Hormone (GnRH)
Show All >>

Therapies Related to Toremifene

  1. Drug Therapy (Chemotherapy)
  2. Intramuscular Injections
  3. Injections
  4. Immunotherapy
  5. Oral Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.